{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:19:38Z","timestamp":1793380778666,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Science Research and Innovation Fund (NSRF) through Khon Kaen University and the National Research Council of Thailand through the Fluke Free Thailand Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97641-9","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T02:49:26Z","timestamp":1744598966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Piya","family":"Prajumwongs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attapol","family":"Titapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasin","family":"Thanasukarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apiwat","family":"Jareanrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natcha","family":"Khuntikeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisana","family":"Namwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poramate","family":"Klanrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arporn","family":"Wangwiwatsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarin","family":"Chindaprasirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supinda","family":"Koonmee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakasit","family":"Sa-Ngiamwibool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattha","family":"Muangritdech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sittiruk","family":"Roytrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watcharin","family":"Loilome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"97641_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"97641_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00268-022-06655-1","volume":"46","author":"A Nassar","year":"2022","unstructured":"Nassar, A. et al. Factors of early recurrence after resection for intrahepatic cholangiocarcinoma. World J. Surg. 46, 2459\u20132467. https:\/\/doi.org\/10.1007\/s00268-022-06655-1 (2022).","journal-title":"World J. Surg."},{"key":"97641_CR3","doi-asserted-by":"crossref","unstructured":"Yamauchi, N. et al. Clinical significance of early recurrence after curative resection of colorectal cancer. Anticancer Res. 42, 5553\u20135559. (2022).","DOI":"10.21873\/anticanres.16061"},{"key":"97641_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/sla.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot, V. P. et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann. Surg. 269, 1154\u20131162. https:\/\/doi.org\/10.1097\/sla.0000000000002734 (2019).","journal-title":"Ann. Surg."},{"key":"97641_CR5","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.21873\/anticanres.16061","volume":"42","author":"N Yamauchi","year":"2022","unstructured":"Yamauchi, N. et al. Clinical significance of early recurrence after curative resection of colorectal cancer. Anticancer Res. 42, 5553\u20135559. https:\/\/doi.org\/10.21873\/anticanres.16061 (2022).","journal-title":"Anticancer Res."},{"key":"97641_CR6","doi-asserted-by":"publisher","unstructured":"Kim, H. S. et al. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer. BJS Open. 5 https:\/\/doi.org\/10.1093\/bjsopen\/zrab127 (2021).","DOI":"10.1093\/bjsopen\/zrab127"},{"key":"97641_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4174\/astr.2021.101.5.266","volume":"101","author":"JS Kang","year":"2021","unstructured":"Kang, J. S. et al. Limits of serum carcinoembryonic antigen and carbohydrate antigen 19\u2009\u2013\u20099 as the diagnosis of gallbladder cancer. Ann. Surg. Treat. Res. 101, 266\u2013273. https:\/\/doi.org\/10.4174\/astr.2021.101.5.266 (2021).","journal-title":"Ann. Surg. Treat. Res."},{"key":"97641_CR8","doi-asserted-by":"crossref","unstructured":"Zhang, A., Sun, H., Yan, G., Wang, P. & Wang, X. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research. Biomed. Chromatogr. 30, 7\u201312 (2016).","DOI":"10.1002\/bmc.3453"},{"key":"97641_CR9","doi-asserted-by":"crossref","unstructured":"Jacob, M., Lopata, A. L., Dasouki, M. & Abdel Rahman, A. M. Metabolomics toward personalized medicine. Mass Spectrom. Rev. 38, 221\u2013238 (2019).","DOI":"10.1002\/mas.21548"},{"key":"97641_CR10","doi-asserted-by":"crossref","unstructured":"Bi, Y. et al. Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma. 23, 326 (2024).","DOI":"10.1186\/s12944-024-02298-4"},{"key":"97641_CR11","doi-asserted-by":"crossref","unstructured":"Silva, A. A. R. et al. Plasma metabolome signatures to predict responsiveness to neoadjuvant chemotherapy in breast cancer. 16, 2473 (2024).","DOI":"10.3390\/cancers16132473"},{"key":"97641_CR12","doi-asserted-by":"crossref","unstructured":"Xie, T. et al. Blood metabolomic profiling predicts postoperative gastrointestinal function of colorectal surgical patients under the guidance of goal-directed fluid therapy. 13, 8929 (2021).","DOI":"10.18632\/aging.202711"},{"key":"97641_CR13","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1038\/s41467-024-47581-1","volume":"15","author":"N Qu","year":"2024","unstructured":"Qu, N. et al. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks. Nat. Commun. 15, 3175. https:\/\/doi.org\/10.1038\/s41467-024-47581-1 (2024).","journal-title":"Nat. Commun."},{"key":"97641_CR14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s10120-020-01065-5","volume":"23","author":"S Kaji","year":"2020","unstructured":"Kaji, S. et al. Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence. Gastric Cancer. 23, 874\u2013883. https:\/\/doi.org\/10.1007\/s10120-020-01065-5 (2020).","journal-title":"Gastric Cancer"},{"key":"97641_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/jjco\/hyac074","volume":"52","author":"Y Wada","year":"2022","unstructured":"Wada, Y. et al. Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer. Jpn J. Clin. Oncol. 52, 887\u2013895. https:\/\/doi.org\/10.1093\/jjco\/hyac074 (2022).","journal-title":"Jpn J. Clin. Oncol."},{"key":"97641_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ijgc-2020-001862","volume":"31","author":"Y Ahmed-Salim","year":"2021","unstructured":"Ahmed-Salim, Y. et al. The application of metabolomics in ovarian cancer management: a systematic review. Int. J. Gynecol. Cancer. 31, 754\u2013774. https:\/\/doi.org\/10.1136\/ijgc-2020-001862 (2021).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"97641_CR17","doi-asserted-by":"publisher","unstructured":"Padthaisong, S. et al. Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. Cancer Metab.. 9 https:\/\/doi.org\/10.1186\/s40170-021-00266-5 (2021).","DOI":"10.1186\/s40170-021-00266-5"},{"key":"97641_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF00994018","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273\u2013297. https:\/\/doi.org\/10.1007\/BF00994018 (1995).","journal-title":"Mach. Learn."},{"key":"97641_CR19","doi-asserted-by":"publisher","first-page":"7562","DOI":"10.1021\/ac800954c","volume":"80","author":"S Mahadevan","year":"2008","unstructured":"Mahadevan, S., Shah, S. L., Marrie, T. J. & Slupsky, C. M. Analysis of metabolomic data using support vector machines. Anal. Chem. 80, 7562\u20137570. https:\/\/doi.org\/10.1021\/ac800954c (2008).","journal-title":"Anal. Chem."},{"key":"97641_CR20","doi-asserted-by":"publisher","unstructured":"Xie, T. et al. Blood metabolomic profiling predicts postoperative gastrointestinal function of colorectal surgical patients under the guidance of goal-directed fluid therapy. Aging 13 https:\/\/doi.org\/10.18632\/aging.202711 (2021).","DOI":"10.18632\/aging.202711"},{"key":"97641_CR21","doi-asserted-by":"publisher","unstructured":"Szczerbinski, L. et al. Untargeted metabolomics analysis of the serum metabolic signature of childhood obesity. Nutrients 14 https:\/\/doi.org\/10.3390\/nu14010214 (2022).","DOI":"10.3390\/nu14010214"},{"key":"97641_CR22","doi-asserted-by":"crossref","unstructured":"Szczerbinski, L. et al. Untargeted metabolomics analysis of the serum metabolic signature of childhood obesity. 14, 214 (2022).","DOI":"10.3390\/nu14010214"},{"key":"97641_CR23","doi-asserted-by":"crossref","unstructured":"Chen, Z., Huang, X., Gao, Y., Zeng, S. & Mao, W. Plasma-metabolite-based machine learning is A.P.omising diagnostic A.proach for esophageal squamous cell carcinoma investigation. J. Pharm. Anal. 11, 505\u2013514 (2021).","DOI":"10.1016\/j.jpha.2020.11.009"},{"key":"97641_CR24","doi-asserted-by":"publisher","first-page":"16351","DOI":"10.1038\/srep16351","volume":"5","author":"DA Gaul","year":"2015","unstructured":"Gaul, D. A. et al. Highly-accurate metabolomic detection of early-stage ovarian cancer. Sci. Rep. 5, 16351. https:\/\/doi.org\/10.1038\/srep16351 (2015).","journal-title":"Sci. Rep."},{"key":"97641_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu, E. L., Nguyen, T., Rhyne, S. & Kim, J. Amino acids in cancer. Exp. Mol. Med. 52, 15\u201330. https:\/\/doi.org\/10.1038\/s12276-020-0375-3 (2020).","journal-title":"Exp. Mol. Med."},{"key":"97641_CR26","doi-asserted-by":"publisher","unstructured":"Chen, J., Cui, L., Lu, S. & Xu, S. Amino acid metabolism in tumor biology and therapy. Cell Death Dis. 15 https:\/\/doi.org\/10.1038\/s41419-024-06435-w (2024).","DOI":"10.1038\/s41419-024-06435-w"},{"key":"97641_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah, E. E. IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J. Translational Med. 20, 347. https:\/\/doi.org\/10.1186\/s12967-022-03554-w (2022).","journal-title":"J. Translational Med."},{"key":"97641_CR28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/sj.bjc.6604485","volume":"99","author":"M Lo","year":"2008","unstructured":"Lo, M., Ling, V., Wang, Y. Z. & Gout, P. W. The xc- cystine\/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br. J. Cancer. 99, 464\u2013472. https:\/\/doi.org\/10.1038\/sj.bjc.6604485 (2008).","journal-title":"Br. J. Cancer"},{"key":"97641_CR29","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature13236","volume":"510","author":"J Fan","year":"2014","unstructured":"Fan, J. et al. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510, 298\u2013302. https:\/\/doi.org\/10.1038\/nature13236 (2014).","journal-title":"Nature"},{"key":"97641_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101\u2013105. https:\/\/doi.org\/10.1038\/nature12040 (2013).","journal-title":"Nature"},{"key":"97641_CR31","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41598-017-02296-w","volume":"7","author":"T De Marchi","year":"2017","unstructured":"De Marchi, T. et al. Phosphoserine aminotransferase 1 is associated to poor outcome on Tamoxifen therapy in recurrent breast cancer. Sci. Rep. 7, 2099. https:\/\/doi.org\/10.1038\/s41598-017-02296-w (2017).","journal-title":"Sci. Rep."},{"key":"97641_CR32","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/ijc.29481","volume":"137","author":"Y Jia","year":"2015","unstructured":"Jia, Y. et al. Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients. Int. J. Cancer. 137, 1095\u20131106. https:\/\/doi.org\/10.1002\/ijc.29481 (2015).","journal-title":"Int. J. Cancer"},{"key":"97641_CR33","doi-asserted-by":"publisher","unstructured":"Damerell, V. et al. Circulating tryptophan\u2013kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I\u2013III colorectal cancer. 156, 552\u2013565 https:\/\/doi.org\/10.1002\/ijc.35183 (2025).","DOI":"10.1002\/ijc.35183"},{"key":"97641_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot, J. et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615, 168\u2013174. https:\/\/doi.org\/10.1038\/s41586-023-05728-y (2023).","journal-title":"Nature"},{"key":"97641_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2220\/biomedres.45.57","volume":"45","author":"Y Ichisaka","year":"2024","unstructured":"Ichisaka, Y., Yano, S., Nishimura, K., Niwa, T. & Shimizu, H. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and Akt. Biomedical Res. (Tokyo Japan). 45, 57\u201366. https:\/\/doi.org\/10.2220\/biomedres.45.57 (2024).","journal-title":"Biomedical Res. (Tokyo Japan)"},{"key":"97641_CR36","doi-asserted-by":"crossref","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer. 122, 4\u201322 (2020).","DOI":"10.1038\/s41416-019-0650-z"},{"key":"97641_CR37","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1007\/s13277-015-3214-8","volume":"36","author":"E Abdelzaher","year":"2015","unstructured":"Abdelzaher, E. & Mostafa, M. F. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence. Tumour Biology: J. Int. Soc. Oncodevelopmental Biology Med. 36, 5473\u20135483. https:\/\/doi.org\/10.1007\/s13277-015-3214-8 (2015).","journal-title":"Tumour Biology: J. Int. Soc. Oncodevelopmental Biology Med."},{"key":"97641_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2013.02.030","volume":"59","author":"Y Morita","year":"2013","unstructured":"Morita, Y. et al. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression. J. Hepatol. 59, 292\u2013299. https:\/\/doi.org\/10.1016\/j.jhep.2013.02.030 (2013).","journal-title":"J. Hepatol."},{"key":"97641_CR39","doi-asserted-by":"publisher","first-page":"696961","DOI":"10.3389\/fphar.2021.696961","volume":"12","author":"J Tomacha","year":"2021","unstructured":"Tomacha, J. et al. Targeting fatty acid synthase modulates metabolic pathways and inhibits cholangiocarcinoma cell progression. Front. Pharmacol. 12, 696961. https:\/\/doi.org\/10.3389\/fphar.2021.696961 (2021).","journal-title":"Front. Pharmacol."},{"key":"97641_CR40","doi-asserted-by":"crossref","unstructured":"Sunshine, H. & Iruela-Arispe, M. L. Membrane lipids and cell signaling. Curr. Opin. Lipidol.  28, 408\u2013413 (2017).","DOI":"10.1097\/MOL.0000000000000443"},{"key":"97641_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1039\/c9mo00128j","volume":"16","author":"J Molendijk","year":"2020","unstructured":"Molendijk, J., Robinson, H., Djuric, Z. & Hill, M. M. Lipid mechanisms in hallmarks of cancer. Mol. Omics. 16, 6\u201318. https:\/\/doi.org\/10.1039\/c9mo00128j (2020).","journal-title":"Mol. Omics"},{"key":"97641_CR42","doi-asserted-by":"crossref","unstructured":"Wolrab, D., Jir\u00e1sko, R., Chocholou\u0161kov\u00e1, M., Peterka, O. & Hol\u010dapek, M. Oncolipidomics: Mass spectrometric quantitation of lipids in cancer research. TrAC Trends Anal. Chem. 120, 115480 (2019).","DOI":"10.1016\/j.trac.2019.04.012"},{"key":"97641_CR43","doi-asserted-by":"publisher","first-page":"15156","DOI":"10.1038\/s41598-022-19576-9","volume":"12","author":"J Nizio\u0142","year":"2022","unstructured":"Nizio\u0142, J. et al. Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer. Sci. Rep. 12, 15156. https:\/\/doi.org\/10.1038\/s41598-022-19576-9 (2022).","journal-title":"Sci. Rep."},{"key":"97641_CR44","doi-asserted-by":"publisher","unstructured":"Yagi, T. et al. Challenges and inconsistencies in using lysophosphatidic acid as a biomarker for ovarian cancer. Cancers 11 https:\/\/doi.org\/10.3390\/cancers11040520 (2019).","DOI":"10.3390\/cancers11040520"},{"key":"97641_CR45","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.18632\/oncotarget.23494","volume":"9","author":"Y Lu","year":"2018","unstructured":"Lu, Y. et al. Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers. Oncotarget 9, 5032\u20135043. https:\/\/doi.org\/10.18632\/oncotarget.23494 (2018).","journal-title":"Oncotarget"},{"key":"97641_CR46","doi-asserted-by":"crossref","unstructured":"Ravipati, S., Baldwin, D. R., Barr, H. L., Fogarty, A. W. & Barrett, D. A. Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients. Metabolomics. 11, 1600\u20131611 (2015).","DOI":"10.1007\/s11306-015-0811-x"},{"key":"97641_CR47","doi-asserted-by":"crossref","unstructured":"Martin-Perez, M., Urdiroz-Urricelqui, U., Bigas, C. & Benitah, S. A. The role of lipids in cancer progression and metastasis. Cell Metab. 34, 1675\u20131699 (2022).","DOI":"10.1016\/j.cmet.2022.09.023"},{"key":"97641_CR48","doi-asserted-by":"publisher","unstructured":"Westheim, A. J. F. et al. The modulatory effects of fatty acids on cancer progression. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11020280 (2023).","DOI":"10.3390\/biomedicines11020280"},{"key":"97641_CR49","doi-asserted-by":"crossref","unstructured":"Zhao, G. et al. Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids. 119, e2203480119 (2022).","DOI":"10.1073\/pnas.2203480119"},{"key":"97641_CR50","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal. Transduct. Target. Therapy. 6, 263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"97641_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin, M. B. et al. The eighth edition AJCC cancer staging manual: continuing to build a Bridge from a population-based to a more personalized approach to cancer staging. Cancer J. Clin. 67, 93\u201399. https:\/\/doi.org\/10.3322\/caac.21388 (2017).","journal-title":"Cancer J. Clin."},{"key":"97641_CR52","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1021\/acs.analchem.6b01481","volume":"88","author":"MR Lewis","year":"2016","unstructured":"Lewis, M. R. et al. Development and application of ultra-performance liquid chromatography-TOF MS for precision large scale urinary metabolic phenotyping. Anal. Chem. 88, 9004\u20139013. https:\/\/doi.org\/10.1021\/acs.analchem.6b01481 (2016).","journal-title":"Anal. Chem."},{"key":"97641_CR53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpha.2014.04.002","volume":"4","author":"Q Wu","year":"2014","unstructured":"Wu, Q. et al. UPLC-Q-TOF\/MS based metabolomic profiling of serum and urine of hyperlipidemic rats induced by high fat diet. J. Pharm. Anal. 4, 360\u2013367. https:\/\/doi.org\/10.1016\/j.jpha.2014.04.002 (2014).","journal-title":"J. Pharm. Anal."},{"key":"97641_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa, H. et al. MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat. Methods. 12, 523\u2013526. https:\/\/doi.org\/10.1038\/nmeth.3393 (2015).","journal-title":"Nat. Methods"},{"key":"97641_CR55","doi-asserted-by":"publisher","unstructured":"Saw, N. et al. Influence of extraction solvent on nontargeted metabolomics analysis of enrichment reactor cultures performing enhanced biological phosphorus removal (EBPR). Metabolites 11 https:\/\/doi.org\/10.3390\/metabo11050269 (2021).","DOI":"10.3390\/metabo11050269"},{"key":"97641_CR56","doi-asserted-by":"crossref","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucl. Acids Res. 52, W398\u2013W406. (2024).","DOI":"10.1093\/nar\/gkae253"},{"key":"97641_CR57","doi-asserted-by":"crossref","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucl. Acids Res. 51, D587\u2013D592. (2022).","DOI":"10.1093\/nar\/gkac963"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97641-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97641-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97641-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T02:49:37Z","timestamp":1744598977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97641-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97641"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97641-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12782"}}